Contact this trialFirst, we need to learn more about you.
Dopamine D2 Receptor Modulator
SEP-363856 for Schizophrenia
Recruiting2 awardsPhase 3
Hickory, North Carolina
This trial will test a new anti-schizophrenia drug in both men and women, 18-65yo, across 24 sites in North America for up to 12 weeks.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.